July 9 (Reuters) - Private equity groups Blackstone and TPG are seeking more than $4 billion for medical technology firm ...

While the company no longer manufactures the radiographic markers, healthcare providers are still advised to monitor patients ...

Private equity groups look to pay down debt and repay investors from one of last year’s biggest leveraged buyouts ...

Medical technology company Hologic (NASDAQ:HOLX) in Q4 CY2024, but sales were flat year on year at $1.02 billion. On the other hand, next quarter’s revenue guidance of $1 billion was less impressive, ...

Blackstone and TPG eye selling Hologic’s surgical unit for $4B+ to cut LBO debt and return investor cash as M&A rebounds.

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) will reveal new technologies reimagining the future of breast health at the 110 th Scientific Assembly and Annual Meeting of the ...

Hologic’s recall of its BioZorb Markers due to complications with the implanted device were recently identified as Class I by FDA after 71 injuries were reported as being related to BioZorb Markers.

Hologic is asking women to #BustTheMyth this Breast Cancer Awareness Month. The provider of breast health products has put a set of myths about cancer, such as the belief women without a family ...

Hologic has not yet completed its financial close processes for the first quarter of fiscal 2023, therefore GAAP financial results for the quarter have not yet been finalized. However, the Company ...

Hologic, Inc. (NASDAQ:HOLX) reported better-than-expected first-quarter financial results after the bell Thursday. Here's a look at the highlights. The Details: Hologic reported quarterly adjusted ...